CMCO COLUMBUS MCKINNON CORP Insider Trading

Director Yeung Rebecca buys 1,000 CMCO shares at $15.03; stock down 63.4% from 52-week high of $40.59

Director Yeung Rebecca purchased 1,000 shares of Columbus McKinnon at $15.03 on 2025-06-05, increasing her holdings from 6,682 to 7,682 shares. The purchase occurs after the stock has declined significantly—down 63.4% from its 52-week high of $40.59 and down 17.2% over the past 90 days. The company's fundamentals present a mixed picture: it generated $4.0M in net income on $234.1M in revenue in the latest quarter, but was unprofitable over its most recent full fiscal year and has experienced -5.0% annual revenue growth year-over-year. The purchase is modest in absolute terms relative to her existing position, representing a 15.0% increase in holdings. This insider buy occurs in the context of both recent price weakness and underlying operational headwinds, requiring monitoring of whether subsequent earnings and revenue trends show stabilization.

Director Jeanne Beliveau-Dunn bought 1,000 shares (1.0K) of CMCO at $13.89 on 2025-06-02; stock now -63.4% from 52-week high.

Beliveau-Dunn purchased 1,000 shares at $13.89, increasing her holdings by 38.8% from 2,576 to 3,576 shares, while Columbus McKinnon stock is trading significantly below recent highs (down 63.4% from the $40.65 52-week peak). The company reported revenue of $234,138,000 and net income of $3,960,000 in the latest quarter but remains unprofitable on a full-year basis with annual revenue declining 5.0% year-over-year. The director's prior purchase at this ticker on 2025-03-14 showed a -29.3% 30-day return, and her cross-ticker buy history exhibits an average 30-day return of -29.3%, suggesting purchases have preceded price weakness rather than strength. With the stock currently at $14.90 versus the transaction price of $13.89, the recent trade has already marginally appreciated, but this single insider's directional activity occurs within a context of deteriorating fundamentals and a depressed valuation relative to recent historical levels.

Director Kathryn V Bohl buys 2,819 shares of CMCO at $17.99; cluster of 3 insider buys in 14 days; stock -59.1% from 52-week high.

Director Kathryn V Bohl purchased 2,819 shares at $17.99 on 2025-03-19, increasing her holdings by 23.5% to 14,812 shares total. This buy is part of a cluster pattern: 2 other insiders also bought within the past 14 days. The stock trades at $18.73 currently, representing -59.1% from its 52-week high of $45.78 and down 48.8% over 90 days. The company shows mixed fundamentals with revenue of $234,138,000.00 and net income of $3,960,000.00 (latest quarter), annual revenue growth of +8.3%, but a P/E of 56.76 suggests elevated valuation relative to near-term earnings. The convergence of multiple insider purchases at depressed price levels against the company's historical trading range warrants attention to whether insiders perceive value at current prices or respond to operational or market-specific developments.

Director Beliveau-Dunn purchases 160 CMCO shares at $18.34; stock down -61.0% from 52-week high to $17.83

Director Jeanne Beliveau-Dunn purchased 160 shares of Columbus McKinnon at $18.34 on 2025-03-14, increasing her holdings from 2,416 to 2,576 shares (+6.6%). The purchase occurs in a context of significant price deterioration: the stock trades at $17.83, which is -61.0% from its 52-week high of $45.78 and -12.9% lower over the trailing 30 days. The company posted $234.1M in latest quarterly revenue with $4.0M net income and an 8.3% annual revenue growth rate, but trades at a 54.03 P/E ratio on a $510.2M market cap. The director's modest $2,934.40 transaction and incremental position increase do not provide sufficient evidence of catalytic conviction amid the pronounced drawdown and elevated valuation multiple.

CMCO President of EMEA & APAC bought 6,000 shares at $16.96; cluster pattern with 2 other insiders in 14 days as stock down -48.5% in 30 days.

Chintapalli Appal, President of EMEA & APAC, purchased 6,000 shares of Columbus McKinnon at $16.96 on 2025-03-06, increasing holdings by 27.9% to 27,522 shares. This buy occurs against significant recent weakness: the stock is -48.5% over 30 days and -54.8% over 90 days, trading at $17.94 versus its 52-week high of $45.78. Notably, 2 other insiders also bought within the past 14 days, forming a cluster pattern. The company's fundamentals remain intact with annual revenue growth of +8.3% and latest quarterly revenue of $234.1M, though the P/E of 54.36 reflects market concerns. The timing and multi-insider participation suggest internal management response to steep recent declines, though the stock remains down 60.8% from its 52-week peak.

Director Abraham Chad R buys 20,000 shares of CMCO for $320,900 across 4 transactions on 2025-03-03; stock down 63.8% from 52-week high.

Director Abraham Chad R completed 4 separate purchases totaling 20,000 shares at prices between $16.02 and $16.10 on 2025-03-03, establishing a $320,900 position at a blended average price of $16.04. The acquisition occurs against a backdrop of significant price deterioration: CMCO is -63.8% from its 52-week high of $45.78 and down 58.3% over the past 90 days. The company's fundamentals show modest growth (+8.3% annual revenue growth, $234.1M revenue) but a elevated P/E of 50.15 despite net income of only $4.0M, suggesting valuation stress. The director's prior cross-ticker selling history exhibits a 100.00% well-timed rate with an average 90-day return of -70.9%, indicating skill at exiting prior to declines, though that track record does not necessarily predict outcomes at CMCO specifically.

Director Michael Dastoor buys 10,000 CMCO shares at $19.21; stock down 59.6% from 52-week high; 3 other insiders bought within 14 days

Dastoor purchased 10,000 shares at $19.21, doubling his holding from 10,366 to 20,366 shares, as COLUMBUS MCKINNON CORP stock sits 59.6% below its 52-week high of $45.78 and has fallen 50.6% over the past 30 days. This is not an isolated move: a cluster of 3 other insiders also bought within the past 14 days, suggesting coordinated confidence despite the steep decline. The company shows positive fundamentals with annual revenue growth of 8.3% and $234.1M in latest-quarter revenue, though the P/E of 56.03 remains elevated relative to recent earnings ($4.0M net income). This concurrent accumulation at depressed levels warrants investor attention to the underlying drivers of the stock's sharp recent drawdown.

CEO Wilson David J. buys 10,857 CMCO shares at $20.50; stock down 55.3% from 52-week high; cluster pattern with 2 other insiders buying in past 14 days.

CEO David J. Wilson purchased 10,857 shares for $222,568.50 on 2025-02-14, increasing his holdings from 130,500 to 141,357 shares (+8.3%). The timing follows a sharp decline: CMCO is trading at $20.47, down 55.3% from its 52-week high of $45.78, and down 43.6% over 30 days. Wilson's prior two buys at CMCO (both on 2024-11-01) showed positive 90-day returns of 23.4% and 22.4% respectively, demonstrating a pattern of well-timed accumulation at this ticker. Significantly, 2 other insiders also bought within the past 14 days, creating a cluster buy pattern that suggests coordinated confidence across the leadership team rather than an isolated position adjustment. Against this backdrop, the company reports FY revenue growth of 8.3% and a P/E of 62.03, warranting examination of whether fundamentals justify the recent sharp price decline and insider accumulation.

Director Colella buys 5,500 shares at $20.47 as stock falls -55.3% from 52-week high; cluster pattern with 2 other insider purchases in 14 days

Director Gerard Colella purchased 5,500 shares at $20.47, representing an initiation of a position with zero prior holdings. The transaction occurs in a context of significant recent weakness: the stock trades -55.3% from its 52-week high of $45.78 and has declined -42.8% over the past 30 days. Additionally, a cluster buy pattern is present, with 2 other insiders also purchasing within the past 14 days, suggesting coordinated interest at depressed levels. The company's fundamentals show moderate health (revenue $234,138,000.00, net income $3,960,000.00, and annual revenue growth of +8.3%), though the elevated P/E of 62.06 reflects market skepticism. This filing merits attention for the convergence of multiple insider buyers during a sharp drawdown, though the outsized valuation multiple warrants careful evaluation of whether the purchases reflect information asymmetry or simply opportunistic buying into weakness.

CMCO Director Stephens buys 1,000 shares at $37.34; 19.9% increase in holdings, but prior CMCO purchase (May 2024) was -13.0% after 90 days.

Christopher J. Stephens, a director at Columbus McKinnon (CMCO), purchased 1,000 shares at $37.34 on 2024-11-14, increasing his total holdings by 19.9% to 6,014 shares. The current price of $37.14 is 18.9% below the 52-week high of $45.78, and the stock has risen 6.2% over the past 30 days and 13.7% over the past 90 days. However, his timing history at this specific ticker is unfavorable: a prior buy on 2024-05-31 resulted in a 90-day return of -13.0%, indicating that his previous CMCO purchase was not well-timed. Fundamentally, the company is reporting negative net income of $-15.0M against quarterly revenue of $242.3M, with a notably elevated P/E of 70.08 despite 8.3% annual revenue growth. The modest share purchase size ($37.3K) and the company's current earnings deficit warrant closer attention to whether this acquisition reflects a contrarian opportunity or misaligned timing relative to operational challenges.